scispace - formally typeset
D

Daniel P. Holt

Researcher at Johns Hopkins University

Publications -  83
Citations -  10198

Daniel P. Holt is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Amyloid & Medicine. The author has an hindex of 27, co-authored 72 publications receiving 9563 citations. Previous affiliations of Daniel P. Holt include University of Illinois at Chicago & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

Synthesis and evaluation of 11c-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents

TL;DR: In vitro and in vivo properties of [(11)C]6-OH-BTA-1 support the choice of this derivative for further evaluation in human subject studies of brain Abeta deposition, and indicate the selective binding of the compound to amyloid plaques and cerebrovascular amyloids.
Journal ArticleDOI

Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B:

TL;DR: It was shown that it is feasible to perform quantitative PIB PET imaging studies that are needed to validate simpler methods for routine use across the AD disease spectrum and the Logan analysis was the method-of-choice for the PIBPET data as it proved stable, valid, and promising for future larger studies and voxel-based statistical analyses.
Journal ArticleDOI

PET imaging of serotonin 1A receptor binding in depression

TL;DR: Serotonin-1A receptor BP is abnormally decreased in the depressed phase of familial mood disorders in multiple brain regions and may be associated with histopathological changes involving the raphe, convergence evidence from postmortem studies of mood disorders suggests.
Journal ArticleDOI

Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain.

TL;DR: The combination of relatively high affinity for amyloid, specificity for staining plaques and neurofibrillary tangles in post-mortem AD brain, and good brain entry and clearance makes [N-methyl-11C]6-Me-BTA-1 a promising candidate as an in vivo positron emission tomography (PET) beta-sheet imaging agent.